FDA Inspection 697924 — Protalix Ltd.
The FDA completed an inspection of Protalix Ltd. on October 17, 2010 in Karmi'El. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 17, 2010
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Karmi'El (Israel)